Literature DB >> 25922418

Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and Pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol.

Sanjay Chhibber1, Shruti Bansal1, Sukhmandir Kaur1.   

Abstract

We investigated the potential of bacteriophages alone as well as in combination with xylitol for tackling mixed-species biofilm of Pseudomonas aeruginosa and Klebsiella pneumoniae. When mixed-species biofilm was established on polycarbonate discs, P. aeruginosa formed the base layer which was physically shielded on the top by K. pneumoniae. Thereafter, mixed-species biofilm was treated with bacteriophages. K. pneumoniae-specific depolymerase-producing phage KPO1K2 caused significant reduction in the count of Klebsiella. In contrast, P. aeruginosa-specific non-depolymerase-producing phage Pa29 failed to cause any reduction in the count of Pseudomonas. However, application of both phages together resulted in significant reduction in the count of both organisms. This suggests that depolymerase produced by phage KPO1K2 hydrolysed the top layer of K. pneumoniae and guided the entry of Pa29 to reach P. aeruginosa lying underneath. This phenomenon was confirmed when K. pneumoniae-specific non-depolymerase-producing phage NDP was used along with Pa29. Pa29 could not penetrate and reach its host bacterium. Xylitol worked synergistically along with the phage, resulting in a significant decrease in counts of both organisms. Disruption of mixed species biofilm by phage and xylitol was confirmed on the basis of the amount of protein and DNA released. This phage-based approach to altering the structural pattern and disrupting the mixed species biofilm is the first of its kind. It can be used as a topical application, a coating for foreign bodies or for aerosol delivery to tackle infections where both pathogens coexist in a biofilm mode.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25922418     DOI: 10.1099/mic.0.000104

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

Review 1.  Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future.

Authors:  Cheng Chang; Xinbo Yu; Wennan Guo; Chaoyi Guo; Xiaokui Guo; Qingtian Li; Yongzhang Zhu
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

Review 2.  Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Authors:  Stephen T Abedon
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-09

3.  Using Bacteriophages as a Trojan Horse to the Killing of Dual-Species Biofilm Formed by Pseudomonas aeruginosa and Methicillin Resistant Staphylococcus aureus.

Authors:  Tamta Tkhilaishvili; Lei Wang; Carsten Perka; Andrej Trampuz; Mercedes Gonzalez Moreno
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

4.  Bacteriophage as an Alternative to Antibiotics Promotes Growth Performance by Regulating Intestinal Inflammation, Intestinal Barrier Function and Gut Microbiota in Weaned Piglets.

Authors:  Yongdi Zeng; Zirui Wang; Tiande Zou; Jun Chen; Guanhong Li; Liuzhen Zheng; Shuo Li; Jinming You
Journal:  Front Vet Sci       Date:  2021-01-27

Review 5.  Bacteriophage-Derived Depolymerases against Bacterial Biofilm.

Authors:  Gracja Topka-Bielecka; Aleksandra Dydecka; Agnieszka Necel; Sylwia Bloch; Bożena Nejman-Faleńczyk; Grzegorz Węgrzyn; Alicja Węgrzyn
Journal:  Antibiotics (Basel)       Date:  2021-02-10

6.  A Novel Approach for Combating Klebsiella pneumoniae Biofilm Using Histidine Functionalized Silver Nanoparticles.

Authors:  Sanjay Chhibber; Vijay S Gondil; Samrita Sharma; Munish Kumar; Nishima Wangoo; Rohit K Sharma
Journal:  Front Microbiol       Date:  2017-06-16       Impact factor: 5.640

Review 7.  Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.

Authors:  Luis Vitetta; Gemma Vitetta; Sean Hall
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

8.  Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities.

Authors:  Ariel J Santiago; Maria L Burgos-Garay; Leila Kartforosh; Mustafa Mazher; Rodney M Donlan
Journal:  AIMS Microbiol       Date:  2020-02-26

Review 9.  Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.

Authors:  Zahra Chegini; Amin Khoshbayan; Majid Taati Moghadam; Iman Farahani; Parham Jazireian; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-30       Impact factor: 3.944

10.  Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa.

Authors:  Sonika Sharma; Sibnarayan Datta; Soumya Chatterjee; Moumita Dutta; Jhuma Samanta; Mohan G Vairale; Rajeev Gupta; Vijay Veer; Sanjai K Dwivedi
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.